These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2906649)

  • 1. [Biochemistry of Parkinson's disease].
    Nagatsu T
    Seikagaku; 1988 May; 60(5):358-66. PubMed ID: 2906649
    [No Abstract]   [Full Text] [Related]  

  • 2. [Parkinson's disease--the molecular mechanism].
    Nagatsu T
    Tanpakushitsu Kakusan Koso; 1990 May; 35(7 Suppl):1341-52. PubMed ID: 1972586
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular biology of catecholamine neurons in relation to Parkinson's disease.
    Nagatsu T; Ichinose H
    Adv Neurol; 1996; 69():147-52. PubMed ID: 8615123
    [No Abstract]   [Full Text] [Related]  

  • 4. Endogenous dopamine-derived neurotoxins and Parkinson's disease.
    Deleu D
    Acta Neurol Belg; 1998 Dec; 98(4):319-21. PubMed ID: 9922818
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pathogenesis of Parkinson's disease, a molecular genetic approach].
    Kaneda N; Nagatsu T
    Rinsho Shinkeigaku; 1989 Dec; 29(12):1510-3. PubMed ID: 2576527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phospholipid in Parkinson's disease: biochemical and clinical data.
    Toffano G; Battistin L
    Prog Clin Biol Res; 1980; 39():205-14. PubMed ID: 6105671
    [No Abstract]   [Full Text] [Related]  

  • 7. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P; Lévesque M; Parent A
    Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ubiquitin pathway in Parkinson's disease.
    Leroy E; Boyer R; Auburger G; Leube B; Ulm G; Mezey E; Harta G; Brownstein MJ; Jonnalagada S; Chernova T; Dehejia A; Lavedan C; Gasser T; Steinbach PJ; Wilkinson KD; Polymeropoulos MH
    Nature; 1998 Oct; 395(6701):451-2. PubMed ID: 9774100
    [No Abstract]   [Full Text] [Related]  

  • 9. Biochemical analysis of caudate nucleus biopsy samples from parkinsonian patients.
    Goldstein M; Lieberman AN; Helmer E; Koslow M; Ransohoff J; Elsworth JD; Roth RH; Deutch AY
    Ann Neurol; 1988 Nov; 24(5):685-8. PubMed ID: 2904793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catecholaminergic neurons in the parabrachial nucleus of normal individuals and patients with idiopathic Parkinson's disease.
    Goto S; Hirano A
    Ann Neurol; 1991 Aug; 30(2):192-6. PubMed ID: 1680303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Abnormalities of catecholamine metabolism in Parkinson's disease (author's transl)].
    Nagatsu T
    Tanpakushitsu Kakusan Koso; 1981 Aug; 26(11):1781-8. PubMed ID: 6117927
    [No Abstract]   [Full Text] [Related]  

  • 12. Biochemistry of the basal ganglia.
    Fahn S
    Adv Neurol; 1976; 14():59-89. PubMed ID: 7932
    [No Abstract]   [Full Text] [Related]  

  • 13. Adrenal transplant, dopaminergic neurons, and Parkinson's disease.
    Anglade P; Hirsch EC; Brandel JP; Javoy-Agid F; Duyckaerts C; Hauw JJ; Agid Y
    Ann Neurol; 1993 Jun; 33(6):662-3. PubMed ID: 8098934
    [No Abstract]   [Full Text] [Related]  

  • 14. Persistent penetration of MPTP through the nasal route induces Parkinson's disease in mice.
    Rojo AI; Montero C; Salazar M; Close RM; Fernández-Ruiz J; Sánchez-González MA; de Sagarra MR; Jackson-Lewis V; Cavada C; Cuadrado A
    Eur J Neurosci; 2006 Oct; 24(7):1874-84. PubMed ID: 17067291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards elucidation of the role of ubiquitination in the pathogenesis of Parkinson's disease with semisynthetic ubiquitinated α-synuclein.
    Hejjaoui M; Haj-Yahya M; Kumar KS; Brik A; Lashuel HA
    Angew Chem Int Ed Engl; 2011 Jan; 50(2):405-9. PubMed ID: 21154793
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease.
    Pérez-H J; Carrillo-S C; García E; Ruiz-Mar G; Pérez-Tamayo R; Chavarría A
    Toxicology; 2014 May; 319():38-43. PubMed ID: 24607817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutamate receptor genes in Parkinson's disease.
    Penney JB; Standaert DG; Testa CM; Landwehrmeyer GB; Young AB
    Adv Neurol; 1996; 69():79-86. PubMed ID: 8615188
    [No Abstract]   [Full Text] [Related]  

  • 18. Natural toxin implicated as triggering Parkinson's disease.
    Pak J Biol Sci; 2011 Feb; 14(3):255. PubMed ID: 21870660
    [No Abstract]   [Full Text] [Related]  

  • 19. Manganese-induced dopaminergic neurodegeneration: insights into mechanisms and genetics shared with Parkinson's disease.
    Benedetto A; Au C; Aschner M
    Chem Rev; 2009 Oct; 109(10):4862-84. PubMed ID: 19534496
    [No Abstract]   [Full Text] [Related]  

  • 20. Tyrosine hydroxylase: human isoforms, structure and regulation in physiology and pathology.
    Nagatsu T
    Essays Biochem; 1995; 30():15-35. PubMed ID: 8822146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.